Director, Medical Strategy
Boehringer Ingelheim Pharmaceuticals, Inc.
Jennifer holds the role of Director, Medical Strategy (Oncology) at Boehringer Ingelheim. She leads/contributes to the execution of U.S. medical strategy in collaboration with internal cross- functional team members. In addition, she develops relationships with outside organizations and experts to support research/clinical development programs, licensed product maintenance and optimization, and life cycle management. Jennifer received a Master of Business Administration from Drexel University, LeBow College of Business (Marketing) and a Doctor of Pharmacy from the University of the Sciences in Philadelphia, Philadelphia College of Pharmacy. She is also a Board Certified Oncology Pharmacist, obtaining her certification in 2012.
